We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Computer Program Predicts Drug Resistance by Evaluating Whole Genome Sequencing Data

By LabMedica International staff writers
Posted on 03 Jan 2016
Print article
Image: A screenshot from the Mykrobe Predictor software package shows results for an analysis of a methicillin-resistant Staphylococcus aureus (MRSA) bacterium (Photo courtesy of Mykrobe [University of Oxford]).
Image: A screenshot from the Mykrobe Predictor software package shows results for an analysis of a methicillin-resistant Staphylococcus aureus (MRSA) bacterium (Photo courtesy of Mykrobe [University of Oxford]).
A software package is being evaluated in the United Kingdom that can identify a bacterium from the DNA sequence of its genome and predict which antibiotics will kill it.

The Mykrobe Predictor software for laptop and tablet computer use was developed by investigators at the University of Oxford (United Kingdom). It supports Illumina Inc. (San Diego, CA, USA) instrument sequencing data as standard input. Antibiotics supported include: Beta-lactams (methicillin, penicillin), quinolones (ciprofloxacin), macrolides/lincosamides (erythromycin, clindamycin), tetracycline, aminoglycosides (gentamicin), glycopeptides (vancomycin), rifampicin, mupirocin, fusidic acid, and trimethoprim.

The program takes raw sequence data as input and generates a clinician-friendly report within three minutes on a laptop or tablet computer.

Mykrobe Predictor is currently being evaluated in three medical centers in the United Kingdom. A preliminary study comprising more than 4,500 retrospective patient samples was published in the December 21, 2015, online edition of the journal Nature Communications. Results highlighted the ability of the Mykrobe Predictor program to accurately detect antibiotic resistance in two life-threatening bacterial infections: Staphylococcus aureus (including MRSA) and Mycobacterium tuberculosis (TB).

For S. aureus, the error rates of the method were comparable to gold-standard phenotypic methods, with sensitivity/specificity of 99.1%/99.6% across 12 antibiotics. For M. tuberculosis, the method predicted resistance with sensitivity/specificity of 82.6%/98.5%. Sensitivity was lower for M. tuberculosis, probably because of limited understanding of the underlying genetic mechanisms.

The program also identified infections caused by a mixture of drug-resistant and drug-susceptible bacteria. This ability to distinguish between bacterial sub-populations gave the Mykrobe Predictor program an advantage over conventional testing in detecting resistance to second-line TB drugs.

Senior author Dr. Zamin Iqbal, a researcher in human genetics at the University of Oxford, said, "One of the barriers to making whole genome sequencing a routine part of NHS care is the need for powerful computers and expertise to interpret the masses of complex data. Our software manages data quickly and presents the results to doctors and nurses in ways that are easy to understand, so they can instinctively use them to make better treatment decisions."

Related Links:

University of Oxford
Mykrobe Predictor
Illumina Inc.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.